Safeguard Scientifics, Inc.

SFES • Asset Management

Movimiento fuerte

SFES-11.36%

vs. cierre anterior $0.44

$0.39

▼ -0.05 (-11.36%)

Precio actual

ResultadosÚltimo reporte: 31 mar 2026

PERFIL DE MAYOR RIESGOPrecauciónConfianza: 70%

Perfil cuantitativo — no constituye una recomendación de inversión.

Perfil cuantitativo — no constituye una recomendación de inversión.Metodología

Tesis del análisis: Conviene actuar con cautela. Los ratios recientes muestran debilidades que pueden limitar el retorno si los fundamentales no mejoran.

Capitalización

$6.52M

Crecimiento

-100.0%

Flujo de caja

0/5

Tendencia

Negative

Evidencia

Múltiplo de ganancias razonable · 8.05Nivel de deuda manejable · 0.02Liquidez saludable · 10.06Rentabilidad débil

Datos financieros hasta: 31 mar 2026, 12:00 a.m. UTCÚltima actualización de earnings: 15 may 2026, 12:00 a.m. UTCÚltima actualización del perfil: 26 ago 2026, 12:18 p.m. UTC

Resumen de la compañía

Valoración, calidad, fortaleza financiera, momentum y datos de analistas.

Price$0.39

Change-11.36%

Shares Out16.72M

Market Cap$6.52M

Enterprise Value$-22.05M

52W Range0.22 - 1.89

Beta-0.92

P/E0.31

P/B0.22

P/FCF-1.88

EV/EBITDA75.50

EV/FCF6.34

Price$0.39

Change-11.36%

Shares Out16.72M

Market Cap$6.52M

Enterprise Value$-22.05M

52W Range0.22 - 1.89

Beta-0.92

P/E0.31

P/B0.22

P/FCF-1.88

EV/EBITDA75.50

EV/FCF6.34

Earnings Yield319.50%

FCF Yield-53.33%

Dividend Yield0.00%

Gross Margin0.00%

Oper. Margin0.00%

Profit Margin0.00%

Debt/Eq0.02

Current Ratio10.06

Quick Ratio10.06

Revenue 5Y-100.00%

Volume100.00

Avg Volume3.33K

EPS Surprise1.44

ADN de inversión

Qué tan fuerte luce esta compañía para inversionistas de largo plazo

de 100

Calidad del negocio

Márgenes, ventaja competitiva, retornos

22/100

Fortaleza financiera

Deuda, caja, estabilidad

76/100

Potencial de crecimiento

Ingresos y expansión

50/100

Atractivo del precio

Barata o cara hoy

94/100

Por qué este puntaje▼

Múltiplo de ganancias razonable · 8.05Nivel de deuda manejable · 0.02Liquidez saludable · 10.06Rentabilidad débil

Analyst view

No analyst data available now.

Resumen de la compañía

IPO: 3/17/1980

Industria: Asset Management

P/B i: 0.22

Deuda / Patrimonio i: 0.02

Margen operativo: 0.00%

Margen neto: 0.00%

ROE i: -

ROIC: -

Salud financiera

Puntaje15 / 20

Deuda / Patrimonio: 0.02

Ratio corriente: 10.06

Ratio rápido: 10.06

Estado: Good

Transacciones internas

Actividad reciente de ejecutivos e insiders

StepStone Group Holdings LLC

Transacción: 12/06/2013

VENTA

Cambio

—

Precio

Not reported

Presentación

12/10/2013

Tipo

VENTA

StepStone Group Holdings LLC

Transacción: 12/06/2013

COMPRA

Cambio

+5,611,555

Precio

Not reported

Presentación

12/10/2013

Tipo

COMPRA

StepStone Group Holdings LLC

Transacción: 09/03/2013

OPCIÓN

Cambio

+5,611,555

Precio

Not reported

Presentación

12/10/2013

Tipo

OPCIÓN

Insider	Tipo	Cambio	Precio	Transacción	Presentación
StepStone Group Holdings LLC	VENTA	—	Not reported	12/06/2013	12/10/2013
StepStone Group Holdings LLC	COMPRA	+5,611,555	Not reported	12/06/2013	12/10/2013
StepStone Group Holdings LLC	OPCIÓN	+5,611,555	Not reported	09/03/2013	12/10/2013
StepStone Group Holdings LLC	OPCIÓN	0	Not reported	09/03/2013	12/10/2013
SLATTERY JOSEPH P	OPCIÓN	+250,000	$0.40	10/02/2013	10/03/2013
SLATTERY JOSEPH P	COMPRA	+1,000,000	Not reported	10/02/2013	10/03/2013
Milne David Bruce	OTRO	0	Not reported	09/03/2013	09/11/2013
LAVIOLETTE PAUL A	VENTA	-28,832	$0.07	09/03/2013	09/11/2013
SVLSF IV, LLC	OPCIÓN	+11,549,790	$0.40	09/03/2013	09/11/2013
SVLSF IV, LLC	VENTA	0	Not reported	09/03/2013	09/11/2013
StepStone Group Holdings LLC	OPCIÓN	0	Not reported	09/03/2013	09/11/2013
AISLING CAPITAL III LP	COMPRA	—	$0.40	09/03/2013	09/05/2013
Dougherty Dennis	COMPRA	+598,706	$0.40	09/03/2013	09/05/2013
SYNERGY LIFE SCIENCE PARTNERS L P	COMPRA	—	$0.40	09/03/2013	09/05/2013
FROST PHILLIP MD ET AL	COMPRA	+742,000	$0.40	09/03/2013	09/05/2013
Dougherty Dennis	OPCIÓN	0	Not reported	09/03/2013	09/04/2013
Kherani Aftab	OTRO	0	Not reported	09/03/2013	09/04/2013
AISLING CAPITAL III LP	OPCIÓN	0	Not reported	09/03/2013	09/04/2013
SYNERGY LIFE SCIENCE PARTNERS L P	VENTA	0	Not reported	09/03/2013	09/04/2013
Martin James Joseph	COMPRA	+70,000	$0.45	04/23/2013	04/25/2013

Sobre la compañía

Safeguard Scientifics, Inc.

Safeguard Scientifics, Inc., a former private equity and venture capital firm, is no longer actively seeking new investments. Historically, the firm specialized in a broad range of financing activities, including providing capital for company expansion and growth, facilitating management buyouts, executing recapitalizations, driving industry consolidations, and supporting corporate spin-offs. Their investment scope covered both early and growth-stage companies. Typically, Safeguard Scientifics participated in Series A, B, or C funding rounds, with an opportunistic approach to seed-stage investments. Their primary sector focus spanned technology, financial services, and healthcare. Within the technology sphere, their interests were diverse, encompassing areas such as software-as-a-service (SaaS), adtech, digital media, the Internet of Everything (IoE), advanced security solutions, predictive analytics, machine learning, artificial intelligence, enterprise software, technology-enabled services, internet/new media, financial technology (FinTech), cloud computing, mobile, social platforms, big data, in-memory computing, and select business services. For these tech ventures, they considered companies requiring up to $25 million in capital. In the healthcare sector, the firm directed its investments towards molecular and point-of-care diagnostics, various medical devices, regenerative medicine, broader medical technology, digital health solutions, healthcare technology, specialized pharmaceuticals, and chosen healthcare services. Geographically, Safeguard Scientifics invested across the entire United States, with a particular emphasis on the Mid-Atlantic region, and also extended its reach into Southeastern Canada. Financial commitments for growth equity financing generally ranged from $5 million to $25 million, while early-stage financings typically saw investments between $5 million and $10 million. The firm's investment strategy often targeted a variety of capital structures, including self-funded (bootstrapped) companies, corporate divisions or business units, and venture capital-backed entities seeking a growth partner. Safeguard Scientifics aimed to be the largest stakeholder in its portfolio companies, typically acquiring an ownership stake between 20% and 50%, though they were flexible and might occasionally take either a majority or a smaller interest. A strong preference existed for companies possessing proprietary technology and intellectual property. Furthermore, the firm routinely sought a Board seat in its invested companies. Founded in 1953 as Lancaster Corporation, the company adopted the name Safeguard Scientifics, Inc. in 1981. Its main office is located in Radnor, Pennsylvania, with an additional presence in Weston, Massachusetts.

Fuente - Link

Competidores

AHFCF BLRZF HCGI MATEF MONTF PIAC PRPS RHCO SNTX TRRPF

Tamaño = capitalización · color = línea del gráfico

Rendimiento de peers · 1A

Top performers + empresa seleccionada

📰

No hay noticias disponibles ahora

Vuelve a revisar más tarde.

Sorpresas de ganancias

Período	Estimado	Real	Sorpresa
2026-05-15	-0.34	1.1	1.44
2026-03-31	-0.29	-0.02	0.27
2021-03-03	-0.27	-0.35	-0.08
2020-11-05	-0.29	-0.21	0.08
2020-08-11	-0.33	-0.48	-0.15
2020-04-30	-0.34	-0.77	-0.43
2020-02-27	-0.39	-0.03	0.36
2019-11-07	-0.545	-0.12	0.425
2013-10-24	-0.54	-0.9	-0.36
2013-07-25	-0.45	-1.33	-0.88
2013-04-25	-0.39	-0.57	-0.18
2013-03-07	-0.23	-0.51	-0.28